Introduction
Chronic rhinosinusitis (CRS) affects 11% of the European population and is associated with a significant socio-economic burden (1, 2) . CRS with and without nasal polyps are the main constituent disease entities with each having different pathophysiological mechanisms or endotypes underlying the disease (3) .
Evidence-based treatment guidelines (EPOS) provide guidance to physicians for the management of CRS aiming at achieving or maintaining clinical control (4) . The cornerstone of CRS treatment is prolonged anti-inflammatory treatment in combination with Functional Endoscopic Sinus Surgery (FESS) in case of failure of medical treatment. Despite currently available treatment modalities for CRS, including sinus surgery, up to 40% of patients still suffer from uncontrolled disease (5) . Few studies so far have evaluated the burden of uncontrolled CRS in real life using the EPOS criteria for CRS disease control (5, 6) .
Uncontrolled upper airway disease might be attributed to disease-, treatment-, diagnosis-and patient-related factors (7) . The relative importance of these factors still needs to be determined but it has been suggested that active participation of patients in the management of their disease may reduce the burden of uncontrolled disease through better adherence and personalized care (8, 9) . Mobile health technology has the potential to increase patient participation via self-management and education. Recently, education and personalized messages were identified in market research by app developers as most effective in changing patient behavior and are easy to implement (10) .
More challenging, but still having a high impact are app features that improve the communication with the healthcare provider (10) . The success of future mobile (m)Health tools likely depends on the inclusion of those features that are lacking in most currently available apps for chronic upper airway diseases.
For example, MASK-rhinitis is a pioneering project allowing allergic rhinitis patients to track their nasal, ocular or lung symptoms and share it with their health care provider (11, 12) . First results demonstrated its utility to phenotype patients with allergic rhinitis (AR) and to evaluate the impact of allergic rhinitis on work productivity (13, 14) . Recently, the use of a visual analogue scale (VAS) on smartphone screens was validated to assess AR control (15) . Follow-up studies are needed to demonstrate its utility in
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improving disease control and adherence to treatment by the use of the app. Currently, different mobile apps related to sinus disease are available but none were developed by medical experts dealing with CRS. EUFOREA started a program to increase patient participation and empowerment in CRS, encouraging them to become active players in the integrated care pathway (16) . This approach fully matches the concept of precision medicine, for which participation of the patient is one of the 4 key pillars (9, 17) . mySinusitisCoach has been developed in collaboration with the EUFOREA network of Rhinology experts, and different national and international bodies representing patients, primary care physicians, pharmacists and the eHealth community. This manuscript describes the developmental process, the different functionalities and the expected benefits of the app. We here aim to inform the Rhinology community about the unique approach used to design, develop and implement the app, which might serve as a state-of-the-art example for other projects.
Identifying the needs in CRS management
The needs of patients with CRS vary depending on the phase of their disease severity, experience and geographical distribution.
It is assumed that patients with upper airway symptoms rely on self-medication and/or over-the-counter treatment to deal with the first symptoms of rhinosinusitis. Early detection of CRS is warranted to avoid delay in presentation to the primary care physician or ENT specialist. An integrated approach aligning different health care providers dealing with CRS is needed to deliver a uniform message to the patient (9) . While newly diagnosed patients need reliable information about their disease and treatment options, patients with established or uncontrolled disease also require closer follow-up of their symptoms and disease control. Additionally, patients undergoing surgery will benefit from intensified monitoring of their symptoms. From the research perspective, there is a need to validate findings from clinical studies with real life data to guarantee applicability at the population level (18) .
Implementation of supported self-management into clinical practice in CRS
Treatment algorithms have been developed and presented in EPOS guidelines (4) . From the patient's perspective, poor adherence to treatment, incorrect use of treatment and limited knowledge about CRS and the treatment options might hamper their path to maintain or achieve optimal disease control (19) (20) (21) .
A blended health care approach is needed where the patient is well informed about the treatment options by the physician, in accordance with the guidelines, allowing the patient to understand the rationale of a treatment decision. Mobile health tools are aimed at supporting this process and allow disease monitoring over time, which contributes to supported selfmanagement of the disease. 
Sinusitis Diary
The Sinusitis Diary is a simple tool to monitor rhinosinusitis symptoms and their impact on lower airway symptoms, sleep quality and work or daily life. This tool relies on a visual analogue scale, allowing the patient to score how bothersome a particular symptom is for him/her on a particular day. A similar system has been used and validated in the past to monitor allergy symptoms (15, 22) . The questions of the Sinusitis Diary are listed in Table 1 . Questions with a previous VAS≤2 (e.g. result of the day before) were dropped from the Diary for 1 week to avoid an overload of questions that might be irrelevant for the patient at that time.
In addition to rhinosinusitis symptoms, medication use is recorded as a last item of the Diary. A weekly reminder to complete the Diary is activated in the app. This can be switched off/on and the time point can be chosen according to the patients' preference.
Feedback to the patient
Upon completion of the Sinusitis Diary, the patient receives feedback about the level of control of his/her global rhinosinusitis symptoms: well controlled (VAS≤2), partly controlled (VAS>2 and VAS≤5), uncontrolled (VAS>5) (5) . The results of the specific • 
VAS for Question

Measuring quality of life SNOT-22 questionnaire
The SinoNasal Outcome Test (SNOT)-22 questionnaire is widely used and validated to assess quality of life in CRS patients, to evaluate treatment effectiveness or to identify patients eligible for sinus surgery (23) (24) (25) (26) . This questionnaire has been included in the app as an optional questionnaire to complete monthly.
EQ-5D-5L questionnaire
The EuroQol-5Dimension-5Level (EQ-5D-5L) generic question- naire is used to assess the general health-related quality of life of chronically ill patients (27) . Five specific dimensions of the patients' health are scored: mobility, self-care, usual activities, pain/ discomfort and anxiety/depression. Such generic questionnaire allows comparison of the patients' overall health across different medical conditions. Similar to the SNOT-22 questionnaire, the EQ-5D-5L questionnaire has been included in the app as an optional questionnaire to complete monthly.
Patient support through reliable education
Patients 
For the healthcare professional
Longitudinal information about disease control and adherence to therapy will be available for the doctor. This information may help to decide upon the best treatment strategy and facilitate the patient-doctor interaction (28) . The educational platform may aid the doctor in providing information on treatment options to the patient or allow referral to the platform which might be time saving. In addition this tool could identify those patients who are in need of more extensive medical or surgical treatment (29) . mySinusitisCoach as mobile App airway symptoms, sleep quality and work productivity.
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In the post-operative setting it may facilitate the follow-up of the surgical intervention as well as duration of effect.
For the scientific community
Currently, guidelines and care pathways are developed based on clinical studies that are performed in highly selected patient populations, for valid scientific reasons, however this does not validate the extrapolation of results achieved into the general population (30) . mySinusitisCoach will provide real life data on the natural course of disease, socio-economic impact of CRS and outcomes of medical as well as surgical interventions. In addition, it allows the evaluation of the impact of CRS on lower
